
CAS Number61849-14-7
SynonymsMFCD00135629; PGI2; Flolan; Prostacyclin sodium; EINECS 234-237-8; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (9α,11α,13E,15S)- (1:1); PG12-NA; (5Z,9a,11a,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic Acid Sodium Salt; U 53217A; PGI2,SODIUM SALT; Sodium PGI2; PGI2-NA; PROSTAGLANDIN I2; Prostaglandin 12; PGI2 sodium; Epoprostenol sodium; Sodium (9α,11α,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oate
Molecular FormulaC20H31NaO5
Molecular Weight374.45
Purity≥96 (HPLC)%
Boiling Point530.2ºC at 760mmHg
Melting Point168-170 °C
Appearancepowder
EINECS263-273-7
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 61849-14-7 |
| Catalog No. | 2A-9010352 |
| Chinese Name | 前列腺素 I2 钠盐 |
| Synonyms | MFCD00135629; PGI2; Flolan; Prostacyclin sodium; EINECS 234-237-8; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (9α,11α,13E,15S)- (1:1); PG12-NA; (5Z,9a,11a,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic Acid Sodium Salt; U 53217A; PGI2,SODIUM SALT; Sodium PGI2; PGI2-NA; PROSTAGLANDIN I2; Prostaglandin 12; PGI2 sodium; Epoprostenol sodium; Sodium (9α,11α,13E,15S)-11,15-dihydroxy-6,9-epoxyprosta-5,13-dien-1-oate |
| Molecular Formula | C20H31NaO5 |
| Molecular Weight | 374.45 |
| Purity | ≥96 (HPLC) |
| Boiling Point | 530.2ºC at 760mmHg |
| Melting Point | 168-170 °C |
| Appearance | powder |
| Water Solubility | H2O: 1 mg/mL Hydrolyzes to 6-ketoprostaglandin F1α |
| Storage Condition | Store in an airtight container in a cool, dry plac |
| Application | Epoprostenol sodium (Prostaglandin I2 (sodium salt)) is a synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), used worldwide to treat pulmonary arterial hypertensio |
| EINECS | 263-273-7 |
| PubChem ID | 24898653 |
| SMILES | CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@](O/2)([H])[C@]1([H])CC2=C\CCCC(O)=O.[Na] |
| InChI | 1S/C20H32O5.Na/c1-2-3-4-8-15(21)10-11-16-17(22)12-18-20(16)14(13-25-18)7-5-6-9-19(23)24;/h7,10-11,15-18,20-22H,2-6,8-9,12-13H2,1H3,(H,23,24);/q;+1/p-1/b11-10+,14-7-;/t15-,16-,17+,18-,20+;/m0./s1 |
| InChI Key | OURCVRVJQMLUNA-QFDVFERUSA-M |
| Beilstein/REAXYS | 6472195 |
| NACRES Code | NA.77 |
| eCl@ss | 42020658 |
| UNSPSC | 12352401 |
| Hazard Symbols | Transport |
| MSDS | msds/10352_1_61849_14_7.pdf |
| Bioactivity | Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH)[1]. Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation[2]. Related Catalog Research Areas >> Cardiovascular Disease Signaling Pathways >> Others >> Others References [1]. Provencher S, et al.Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterialhypertension. PLoS One. 2015 Mar 20;10(3):e0120657. Chemical & Physical Properties Boiling Point 530.2ºC at 760mmHg Melting Point 168-170 °C Molecular Formula C20H31NaO5 Molecular Weight 374.447 Flash Point 182.1ºC Exact Mass 374.206909 PSA 89.82000 LogP 2.07380 InChIKey LMHIPJMTZHDKEW-HIHHSTLZSA-M SMILES CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)[O-])CC21.[Na+] Storage condition −20°C Water Solubility H2O: 1 mg/mL Hydrolyzes to 6-ketoprostaglandin F1α in aqueous solution. |
| Use of | Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH)[1]. Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation[2]. Properties Articles36 Name prostacyclin sodium salt Synonym More Synonyms Epoprostenol sodium Biological Activity Description Epoprostenol sodium (Prostaglandin I2 (sodium salt)), the synthetic form of the natural prostaglandin derivative prostacyclin (prostaglandin I2), is registered worldwide for the treatment of Pulmonary arterial hypertension (PAH)[1]. Epoprostenol sodium is used in pulmonary hypertension and transplantation as a potent inhibitor of platelet aggregation[2]. Related Catalog Research Areas >> Cardiovascular Disease Signaling Pathways >> Others >> Others References [1]. Provencher S, et al.Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterialhypertension. PLoS One. 2015 Mar 20;10(3):e0120657. Chemical & Physical Properties Molecular Formula C20H31NaO5 Exact Mass 374.206909 PSA 89.82000 LogP 2.07380 InChIKey LMHIPJMTZHDKEW-HIHHSTLZSA-M |
| Transport Info | Product name: Purity: 96.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: Non-dangerous goods IMDG Code: Non-dangerous goods International air transport dangerous goods regulations: non-dangerous goods 14.3 Transport hazard categories European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.4 Package group European Land Transport Dangerous Regulations: -International Maritime Dangerous Regulations: -International Air Transport Dangerous Regulations: - 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Epicillin | 26774-90-3 | 2A-9010344 |
| Epimedium P.E. | 108929-04-0 | 2A-9010345 |
| Epinastine | 80012-43-7 | 2A-9010346 |
| Epinastine hydrochloride | 80012-44-8 | 2A-9010347 |
| Eplerenone | 107724-20-9 | 2A-9010351 |
| Epoxiconazole | 135319-73-2 | 2A-9010353 |
| Eprazinone | 10402-90-1 | 2A-9010354 |
| Eproxindine | 83200-08-2 | 2A-9010356 |
| Eptaplatin | 146665-77-2 | 2A-9010357 |
| Eptazocine | 72522-13-5 | 2A-9010358 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA